NeuroSphere, McGill’s neuroscience innovation accelerator, is pleased to announce the ten grant recipients from its first Ignite competition, which launched in Fall 2019. As the first of two phases in the HBHL Neuro-Commercialization Grants program, the objective of the Ignite Grants program is to support small-scale validation and proof-of-principle efforts in the development of a neuroscience-related technology. The second phase of the program, the Accelerate Grants, is meant to support research aimed at improving a technology's commercial potential and to position it for commercial development.
NeuroSphere is thrilled that these projects span from drug discovery to medical devices and softwares, and cover various domains of neuroscience.
|Principal Investigator||Project Title|
|Dr. Reza Sharif-Naeini||MP3 - A Personalized Pain Management Platform|
|Dr. Derek Bowie||Therapeutic treatment for Fragile X syndrome|
|Dr. Gabriella Gobbi||Cannabidiol for neuropathic pain and insomnia|
|Dr. Guy Rouleau||Clinical development of guanabenz as a potential disease-modifying therapy for the rare disease spastic paraplegia 4|
|Dr. Nicolas Moitessier||Prolyl oligopeptidase inhibitors as potential Parkinson’s disease therapeutics|
|Dr. Gerhard Multhaup||AIP trap technology to prevent cognitive decline|
|Dr. Nancy Mayo||User interface development for therapeutic wearable: Heel2Toe Sensor|
|Dr. Étienne de Villers-Sidani||Design and implementation of novel functional eye-tracking biomarkers for neurodegenerative diseases|
|Dr. Diane Boivin||Personalized worker fatigue risk estimator|
|Dr. Ridha Joober||Using novel AI-based techniques to model development of side effects in response to treatment in children with ADHD|
The second Ignite and the first Accelerate competitions are planned for launch in early 2021—stay tuned!
If you have any questions, don’t hesitate to neurosphere [at] mcgill.ca (contact NeuroSphere by email).